June 2023

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing symptoms and providing supportive care. Reporting June 1 in the journal Cell Stem Cell, researchers from Japan show in an early clinical trial that the Parkinson's disease drug ropinirole is safe to use in ALS patients and delayed disease progression by 27.9 weeks on average.

Located in Cherlapally, Hyderabad, India, Sunrise International Labs Ltd is a 100 percent wholly owned subsidiary of Perdaman Pharmaceuticals Pvt Ltd, a company that specialise in the manufacture and export of various pharmaceutical product formulations such as tablets, capsules, liquid orals and sachets. Established in 1993,  Sunrise International Labs Ltd is well known for its expertise in drug delivery systems, and has continued to expand its varied product portfolio over the decades, covering a wide range of therapeutic segments.

Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day.

Post : Chemical Researcher

Government has banned 14 FDCs after recommendations of the Expert Committee which stated that there is no therapeutic justification for these FDCs and the FDCs may involve risk to human beings.

The Central Government in exercise of the powers conferred by section 26A of the Drugs and Cosmetics act 1940 (23 of 1940) prohibited the manufacture for sale, sale and distribution for human use of 14 drug FDCs (fixed dose combinations).

For the recruitment of various vacant posts under the National Health Mission, Mission Director, National Health Mission, Raipur, in compliance with the order number / NHM / HR/2023 / NS-48/328 Nava Raipur Atal Nagar dated 04/05/2023, former R.O. On the basis of the approval received in P. NHM for filling the vacant posts. Contractual recruitment is to be done on the basis of prescribed criteria in Chhattisgarh Human Resource Policy 2018.

Established on October 1, 1933 as University Department of Chemical Technology (popularly called UDCT) of the University of Bombay (now Mumbai), with the noble intention of advancing India’s knowledge reserves in chemical science and technology, the Institute has grown to become a premier (deemed) university devoted to education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.

Malabar Cancer Centre, Thalassery is an autonomous institution under Health and Family Welfare Department, Government of Kerala, established under Societies Registration Act XXI of 1860. The institution is located at Kodiyeri, Thalassery of Kannur District and was established in 2001 and the clinical services were started in the same year.

Established on October 1, 1933 as University Department of Chemical Technology (popularly called UDCT) of the University of Bombay (now Mumbai), with the noble intention of advancing India’s knowledge reserves in chemical science and technology, the Institute has grown to become a premier (deemed) university devoted to education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).